ARCHIVES

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

Arimidex Continues To Show Improvement Over Tamoxifen

December 27, 2002

Bishop: Scientists Need Seat At NCI Executive Committee, More Voice In Decision Making

February 24, 1995

BSA, BSC Approve Concept for NCI Scholars Program

March 7, 1997

OHSU Get $500 Million Pledge; Funds to be Matched in Two Years

September 27, 2013

Skipper To Receive Bristol-Myers Award

March 14, 1980

In Brief: Wyeth-Ayerst To donate hormone Replacement Therapy To NIH For Women’s Health Initiative

April 23, 1993